Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone.

Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone. by Jones RN, Erwin ME, Biedenbach DJ, Johnson DM and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 1999; 35 (3): 227-234